BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Superinvestors holding ONC, Q2 2026
No superinvestor reported holding ONC in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ONC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2025
1 superinvestor holding at quarter end
- Sold out
- Greenwoods Asset Management
Q2 2025
2 superinvestors holding at quarter end
- Added
- Greenwoods Asset Management (+66.2%)
Q1 2025
2 superinvestors holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−72.8%), Greenwoods Asset Management (−69.6%)
Q4 2024
2 superinvestors holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−26.5%)
Q3 2024
2 superinvestors holding at quarter end
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−5.4%)
Q3 2021
1 superinvestor holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
2 superinvestors holding at quarter end
- Added
- Maverick Capital (+1.9%)